✦ LIBER ✦

Timing and quantification of bone loss in cardiac transplant recipients

✍ Scribed by Johan Cleemput; Wim Deanen; Jos Nijs; Piet Geusens; Jan Dequeker; Johan Vanhaecke

Publisher: Springer
Year: 1995
Tongue: English
Weight: 427 KB
Volume: 8
Category: Article
ISSN: 0934-0874
DOI: 10.1007/bf00336537

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Calcitonin, Etidronate, and Calcidiol Tr

Calcitonin, Etidronate, and Calcidiol Treatment in Bone Loss after Cardiac Transplantation

✍ I. Garcia-Delgado; S. Prieto; L. Gil-Fraguas; E. Robles; J. J. Rufilanchas; F. H 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 72 KB

Bone loss after cardiac transplantation:

Bone loss after cardiac transplantation: Effects of calcium, calcidiol and monofluorophosphate

✍ E. Meys; F. Terreaux-Duvert; T. Beaume-Six; G. Dureau; P. J. Meunier 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 957 KB

Emergence of Cotrimoxazole- and Quinolon

Emergence of Cotrimoxazole- and Quinolone-ResistantCampylobacterInfections in Bone Marrow Transplant Recipients

✍ S. Lau; P. Woo; K. Leung; K. Yuen 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 25 KB

Diagnosis of pulmonary toxoplasmosis by

Diagnosis of pulmonary toxoplasmosis by bronchoalveolar lavage in cardiac transplant recipients

✍ Steven M. Gordon; Anthony A. Gal; Gary L. Hertzler; John A. Bryan; Carl Perlino; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

A longitudinal study of oral ulcerative

A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients

✍ Sook-Bin Woo; Stephen T. Sonis; Michael M. Monopoli; Andrew L. Sonis 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

Hepatitis A antibodies in liver transpla

Hepatitis A antibodies in liver transplant recipients: Evidence for loss of immunity posttransplantation

✍ Mehmet Arslan; Russell H. Wiesner; John J. Poterucha; B.John Gross Jr; Nizar N. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

Liver transplant recipients frequently have chronic liver diseases and should be considered for vaccination against hepatitis A virus (HAV). However, persistence of protective antibodies after orthotopic liver transplantation (OLT) has not been shown in this population, which may have implications f